Treatment advances for cocaine-induced ischemic stroke: Focus on dihydropyridine-class calcium channel antagonists

American Journal of Psychiatry

Volumn 158, Issue 8, 2001, Pages 1191-1198

  Johnson, B A ^a   Devous M D , Sr ^a   Ruiz, P ^a   Ait Daoud, N ^a  

^a START Center for Cancer Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMILORIDE; ANTICOAGULANT AGENT; BRAIN MONOAMINE; BUPRENORPHINE; CALCIUM CHANNEL BLOCKING AGENT; COCAINE; DARODIPINE; DIHYDROPYRIDINE DERIVATIVE; DIZOCILPINE; DOPAMINE; EXCITATORY AMINO ACID; GABAPENTIN; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; ISRADIPINE; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; LAMOTRIGINE; NIMODIPINE; NITRENDIPINE; PHENCYCLIDINE; POTASSIUM SPARING DIURETIC AGENT; RITANSERIN; SEROTONIN 2 ANTAGONIST; SPASMOLYTIC AGENT;

ATTENTION; BLEEDING; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN VASOSPASM; CEREBROVASCULAR ACCIDENT; COCAINE DEPENDENCE; COGNITIVE DEFECT; DISEASE COURSE; DRUG MECHANISM; DRUG WITHDRAWAL; HUMAN; MEMORY; NERVE CELL NECROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; REVIEW; RISK ASSESSMENT; STROKE; THROMBOGENESIS; TREATMENT OUTCOME; VASCULITIS;

BRAIN ISCHEMIA; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR ACCIDENT; COCAINE-RELATED DISORDERS; DIHYDROPYRIDINES; HUMANS; ISRADIPINE; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASOSPASM, INTRACRANIAL;

EID: 0034891854     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.8.1191     Document Type: Review

References (78)

1. Stroke associated with cocaine use
2. Biopsy-proven cerebral vasculitis associated with cocaine abuse
3. Stroke and cocaine or amphetamine use
4. Neurovascular complications of cocaine
5. Cerebrovascular complications of the use of the "crack" form of alkaloidal cocaine
6. Magnetic resonance imaging evidence of "silent" cerebrovascular toxicity in cocaine dependence
7. The neurovascular complications of cocaine
8. Cocaine abuse and dependence
9. Cerebral blood flow in chronic cocaine users: A study with positron emission tomography
10. Cerebral abnormalities in cocaine abusers: Demonstration by SPECT perfusion brain scintigraphy: Work in progress
11. Cerebral perfusion and neuropsychological consequences of chronic cocaine use
12. Regional cerebral blood flow and cocaine abuse
13. Cocaine decreases relative cerebral blood volume in humans: A dynamic susceptibility contrast magnetic resonance imaging study
14. Vasospasm/thrombus in cerebral ischemia related to cocaine abuse
15. Isradipine prevents global and regional cocaine-induced changes in brain blood flow: A preliminary study
16. Cellular and molecular mechanisms of drug dependence
17. The dopamine hypothesis of the reinforcing properties of cocaine
18. Pharmacokinetics and effect of cocaine on cerebral blood flow in the newborn
19. Cocaine-induced cerebrovasospasm and its possible mechanism of action
20. Cocaine and its metabolites constrict cerebral arterioles in newborn pigs
21. Cocaine and benzoylecgonine constrict cerebral arteries by different mechanisms
22. Depression of cerebral metabolism by stimulant doses of cocaine
23. Intracerebral hemorrhage revisited
24. Demonstration of dose-dependent global and regional cocaine-induced reductions in brain blood flow using a novel approach to quantitative single photon emission computerized tomography
25. Dopaminergic regulation of cerebral cortical microcirculation
26. Pericyte physiology
27. Relaxation of retinal pericyte contractile tone through the nitric oxide-cyclic guanosine monophosphate pathway
28. Acute cocaine results in rapid rises in intracellular free calcium concentration in canine cerebral vascular smooth muscle cells: Possible relation to etiology of stroke
29. Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloidal cocaine
30. Repeated cocaine administration reduces bradykinin-induced dilation of pial arterioles
31. Endothelium-dependent vasorelaxation is impaired in cocaine arteriopathy
32. Arteriosclerotic toxicity of cocaine
33. Arterial injury in rabbits following alternate day injections of cocaine
34. Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography
35. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans
36. The platelet-derived growth factor
37. Platelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in vitro cocaine treatment
38. Cocaine alters placental production of thromboxane and prostacyclin
39. Cocaine administration enhances platelet reactivity to subendothelial components: Studies in a pig model
40. Cocaine does not affect prostacyclin, thromboxane or prostaglandin E production in human umbilical veins
41. Cocaine and vasospasm
42. Prostaglandin hydroperoxidase, an integral part of prostaglandin endoperoxide synthetase
43. Quantitative magnetic resonance imaging in heroin- and cocaine-dependent men: A preliminary study
44. Structure expression and functional analysis of a Na+-dependent glutamate/aspartate transporter from rat brain
45. Calcium - A life and death signal
46. SPECT regional cerebral blood flow and neuropsychological testing in non-demented HIV-positive drug abusers: Preliminary results
47. Neuropsychological functioning in cocaine abusers with or without alcohol dependence
48. Attentional functioning in abstinent cocaine abusers
49. Abstinence symptomatology and neuropsychological impairment in chronic cocaine abusers
50. Reaction time during cocaine versus alcohol withdrawal: Longitudinal measures of visual and auditory suppression
51. Vigilance in recovering cocaine-dependent and alcohol-dependent patients: A prospective study
52. Motoric signs of CNS dysfunction associated with alcohol and cocaine withdrawal
53. Cocaine-induced reduction of glucose utilization in human brain: A study using positron emission tomography and [fluorine 18]fluorodeoxyglucose
54. Morphine-induced metabolic changes in human brain: Studies with positron emission tomography and [fluorine 18]fluorodeoxyglucose
55. Severe non-occlusive ischemic stroke in young heroin addicts
56. Regional cerebral blood flow imaging with SPECT in psychiatric disease: Focus on schizophrenia, anxiety disorders, and substance abuse
57. PET imaging studies in drug abuse
58. A comparison of brain perfusion SPECT in cocaine abuse and AIDS dementia complex
59. Regional cerebral blood flow improves with treatment in chronic cocaine polydrug users
60. Brain perfusion is abnormal in cocaine-dependent polydrug users: A study using technetium-99m-HMPAO and ASPECT
61. Cerebral blood flow changes with acute cocaine intoxication: Clinical correlations with SPECT, CT, and MRI
62. Neuropsychiatric effects of cocaine: SPECT measurements
63. Correlation of acute cocaine-induced changes in local cerebral blood flow with subjective effects
64. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects
65. Reduction of neural damage in irreversible cerebral ischemia by calcium antagonists
66. Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging
67. The effect of isradipine on the central and cerebral hemodynamics of patients with circulatory encephalopathy and hypertension
68. Cerebrovascular, biochemical, and cytoprotective effects of isradipine in laboratory animals
69. Isradipine, a calcium channel blocker, attenuates the ischemia-induced release of dopamine but not glutamate in rats
70. Isradipine attenuates the ischemia-induced release of dopamine in the striatum of the rat
71. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects
72. Biosynthesis, characterization and inhibition of leukotriene B4 in human whole blood
73. Pharmacotherapy of cerebral ischemia in cocaine dependence
74. Effects of amiloride analogues on AVP binding and activation of V1-receptor-expressing cells
75. Inhibition of serotonin-amplified human platelet aggregation by ketanserin, ritanserin, and the ergoline 5HT2 receptor antagonists-LY53857, sergolexole, and LY237733
76. Effect of ritanserin, a 5-hydroxytryptamine2-receptor antagonist, on platelet function and thrombin generation at the site of plug formation in vivo
77. Introduction to the role of excitatory amino acids in the actions of abused drugs: A symposium presented at the 1993 annual meeting of the College on Problems of Drug Dependence
78. Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism